Jubira Gold 10 Capsule is a combination medication containing Aspirin (75mg), Rosuvastatin (10mg), and Clopidogrel (75mg), formulated to manage and reduce the risk of cardiovascular events in patients with a history of coronary artery disease, stroke, or peripheral arterial disease. Aspirin acts as an antiplatelet agent by irreversibly inhibiting cyclooxygenase, thereby reducing thromboxane A2 synthesis and preventing platelet aggregation. Clopidogrel, another antiplatelet agent, selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet receptor, further preventing platelet activation and aggregation. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C), contributing to the stabilization of atherosclerotic plaques and reduction of cardiovascular risk. This combination therapy is indicated for secondary prevention of atherosclerotic events in high-risk patients. Caution is advised in patients with bleeding disorders, hepatic impairment, or hypersensitivity to any component. Regular monitoring of liver function tests, lipid profiles, and complete blood counts is recommended during therapy. Jubira Gold 10 Capsule should be used under medical supervision to optimize cardiovascular outcomes and minimize adverse effects.